Discover how Michael overcame advanced head and neck cancer, maintained hope through social media support, and now advocates for others facing the challenges of diagnosis, treatment, and financial strain.
Shattering Expectations: an Inspiring Road to No Evidence of Disease Read More »
Discover how a 56-year-old patient with BRCA2-positive ovarian cancer navigated neoadjuvant chemo, interval debulking, and PARP inhibitor therapy—ultimately facing therapy-related AML and a tragic outcome.
A Complex Fight: From Initial Complete Response to Recurrence and Therapy-Related AML Read More »
Discover how an 82-year-old with stage IIIC ovarian cancer fought recurrence using cytoreductive surgery, combination chemotherapy, and bevacizumab, gaining temporary remission before ultimately succumbing to her disease in 2009.
Overcoming Recurrent Ovarian Cancer: A Legacy of Hope at 82 Read More »
Discover how one patient with stage IIIC high-grade serous ovarian cancer achieved complete surgical resection via robotic techniques, completed carboplatin-paclitaxel therapy, and remains cancer-free on PARP maintenance 27 months later.
How One Patient Overcame Hidden Metastases and Now Thrives on Maintenance PARP Therapy Read More »
Discover how a 64-year-old patient with advanced, BRCA1/2 wild-type ovarian cancer overcame recurrence through surgical debulking, platinum re-challenge, and targeted rucaparib maintenance therapy.
Battling Advanced Ovarian Cancer: A 64-Year-Old’s Path to Targeted Maintenance Read More »
Discover how a BRCA1/2-negative Stage IIIC HGSC ovarian cancer patient overcame multiple brain metastases with surgery, targeted radiotherapy, and olaparib maintenance—remaining disease-free 63 months after diagnosis.
Defying Stage IIIC Ovarian Cancer: One Patient’s 63-Month Triumph Read More »
Discover how one 74-year-old patient with BRCA2-mutated Stage IVB ovarian cancer achieved 57 months of survival and avoided brain metastasis recurrence through gamma knife radiotherapy, targeted chemotherapy, and PARP inhibition.
Triumph Over Advanced HGSC: A 74-Year-Old’s 57-Month Survival Story Read More »
A second chance after a devastating stage 4 lung cancer diagnosis: Discover how Andrea R. regained hope through immunotherapy and the dedicated care of her medical team.
Finding Light in the Darkest Hour: A Busy Mom’s Stage IV Lung Cancer Miracle Read More »
A 53-year-old named Laurent was diagnosed with stage 4 lung cancer in June 2018. After immunotherapy and chemotherapy, he is now nearly in complete remission—proof that hope and advanced treatments can make all the difference.
Finding Hope and Strength: Laurent’s Triumph Over Stage IV Lung Cancer Read More »
Tejas P., MD, Assistant Professor, Medicine-Medical Oncology, University of Colorado Anschutz Medical Campus, and lung cancer survivor Lysa B. discuss how targeted therapy for ROS1-positive lung cancer offers hope and a better quality of life.
Rewriting the Rules: 12 Years of Targeted Therapy for Lysa’s Rare Lung Cancer Read More »
